Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
145.00    3.00 (2.11%)
Bid:
140.50
Ask:
144.50
Spread: 4.00 (2.847%)
Market Cap: £113.79m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Trading Statement

14 Jan 2026 07:00

RNS Number : 7757O
Xaar PLC
14 January 2026
 

 

14 January 2026

 

 

Xaar plc

("Xaar", the "Group" or the "Company")

 

2025 trading update and notification of full year results

 

Xaar, the inkjet printing technology Group, today issues a trading update for the year ended 31 December 2025.

 

Revenue in the twelve months to 31 December 2025 is expected to be up 16.6% on a like-for-like basis (adjusting for currency and ceased operations) at £60.3 million (2024: £61.4 million,) 

 

Revenues in core ceramics segments have been stable, with growth coming from newer products and markets, notably jewellery wax. Printhead revenue growth was 28.9%.

 

Gross margins have benefitted from volume performance and cost control and the Group expects full year adjusted profits to be marginally ahead of expectation.

 

The year-end net cash position is around £4.8m (2024: £8.2m) after capital investment of £3.1m.

 

Xaar's differentiated technology allows the precise deposition of specialist fluids. Over the last five years the Group has been developing this unique capability for new applications beyond its core ceramics market. The benefits of these developments are evident in 2025 revenues and, while the timing of such projects can be uncertain, the Board is optimistic about the range and scale of the opportunities ahead.

 

Xaar is pleased to announce the appointment of Joh. Berenberg, Gossler & Co KG, London Branch ("Berenberg") and Singer Capital Markets ("Singer") as joint Corporate Brokers, with immediate effect.

 

The full year results will be published on Tuesday 24 March 2026 and there will be a meeting for analysts and institutional investors at 9.15am on the day. For details, please contact Xaar via investor.relations@Xaar.com.

 

Berenberg +44 (0)20 3207 7800

Harry Nicholas

Tom Ballard

 

Singer +44 (0)207 496 3000

Sara Hale

Graham Hertrich

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTKXLFFQFLZBBX
Date   Source Headline
13th Mar 200810:21 amRNSDividend Payment Date
13th Mar 20087:01 amRNSFinal Results
19th Feb 20087:00 amRNSNotice of Final Results
8th Feb 20087:00 amRNSCustomer product launch
30th Jan 20087:00 amRNSDirectorate Change
29th Jan 20087:01 amRNSControl change for partner
10th Jan 20087:01 amRNSYear end trading update
9th Jan 20087:00 amRNSHolding(s) in Company
4th Jan 20083:59 pmRNSTotal Voting Rights
2nd Jan 20089:53 amRNSHolding(s) in Company
11th Dec 200712:25 pmRNSHolding(s) in Company
6th Dec 20075:17 pmRNSTotal Voting Rights
30th Nov 200710:26 amRNSHolding(s) in Company
30th Nov 20077:00 amRNSHolding(s) in Company
27th Nov 200710:12 amRNSHolding(s) in Company
31st Oct 20078:30 amRNSHolding(s) in Company
17th Oct 20076:36 pmRNSHolding(s) in Company
15th Oct 20077:00 amRNSAppointment of Director
5th Oct 20075:46 pmRNSDirector/PDMR Shareholding
12th Sep 20077:01 amRNSInterim Results
11th Sep 20077:03 amRNSNew customer product launches
4th Sep 20075:39 pmRNSTotal Voting Rights
3rd Sep 20077:02 amRNSNotice of Interim Results
21st Aug 20075:29 pmRNSHolding(s) in Company
17th Aug 20076:00 pmRNSHolding(s) in Company
17th Aug 20075:40 pmRNSHolding(s) in Company
6th Aug 20077:00 amRNSDirector/PDMR Shareholding
2nd Aug 20074:30 pmRNSTotal Voting Rights
17th Jul 20077:00 amRNSAppointment of R&D Director
13th Jul 200711:05 amRNSHolding(s) in Company
11th Jul 20077:00 amRNSDirector/PDMR Shareholding
11th Jul 20077:00 amRNSTotal Voting Rights
10th Jul 20077:00 amRNSPeriod End Trading Statement
9th Jul 20075:45 pmBUSDutton Associates Announces Investment Opinion: Xaar Plc Rated Buy in Update Report by Dutton Associates
4th Jun 200710:51 amRNSHolding(s) in Company
24th May 20076:11 pmRNSDirector/PDMR Shareholding
24th May 20071:10 pmRNSHolding(s) in Company
23rd May 20077:00 amRNSFacility visit
16th May 20077:01 amRNSAppointment of Chairman
14th May 20077:00 amRNSDirector/PDMR Shareholding
10th May 20076:05 pmRNSDirector/PDMR Shareholding
9th May 20076:19 pmRNSDirector/PDMR Shareholding
1st May 20076:24 pmRNSDirector/PDMR Shareholding
1st May 200711:37 amRNSHolding(s) in Company
24th Apr 200710:20 amRNSDirector/PDMR Shareholding
23rd Apr 200712:56 pmRNSResult of AGM
23rd Apr 20077:01 amRNSAGM Trading Update
13th Apr 20075:00 pmBUSDutton Associates Announces Investment Opinion: Xaar plc Buy Rating Maintained In Update Coverage By Dutton Associates
11th Apr 200711:55 amRNSAnnual Information Update
29th Mar 20071:27 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.